首页 > 最新文献

Epidemiologie Mikrobiologie Imunologie最新文献

英文 中文
Corynebacterium durum and possibilities of its identification. 硬棒状杆菌及其鉴定的可能性。
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6492/20250428/140417
P Vítková, O Bechyňková, J Scharfen, V Buchta

Corynebaterium (C.) durum is a part of the resident human oral microbiota. Its role in the aetiology of infectious diseases is ambiguous. With the increasing number of immunocompromised patients, it must be considered a potential opportunistic pathogen. It is isolated from the sputum, bronchoalveolar-lavage fluid, as well as blood, especially from immunocompromised patients with pneumonia. In that case, the critical steps involve a correct identification of Corynebacterium to the species level and right interpretation of the findings. The previously widely used commercial test for the identification of Corynebacteria (API Coryne, BioMerieux) is not suitable for all species, including C. durum, as its biotype number is not included in the database. But the obtained result can be compared with the available literature data. Chemotaxonomic and proteomic analysis (matrix-assisted laser desorption/ ionization - time of flight, MALDI-TOF MS) or 16S rRNA sequencing allow for accurate differentiation from the other Corynebacteria species. Nevertheless, these methods are not routinely used in clinical laboratories. A polyphasic approach to the taxonomy based on the data from combined laboratory tests is crucial.

棒状杆菌(C.)硬膜是常驻人类口腔微生物群的一部分。它在传染病病原学中的作用尚不明确。随着免疫功能低下患者数量的增加,必须将其视为潜在的机会性病原体。它从痰液、支气管肺泡灌洗液和血液中分离出来,特别是从免疫功能低下的肺炎患者中。在这种情况下,关键的步骤包括在物种水平上正确识别棒状杆菌和正确解释研究结果。以前广泛使用的商业鉴定杆状菌(API Coryne, BioMerieux)的检测方法并不适用于包括C. durum在内的所有菌种,因为其生物型号未纳入数据库。但所得结果可与现有文献数据进行比较。化学分类和蛋白质组学分析(基质辅助激光解吸/电离-飞行时间,MALDI-TOF MS)或16S rRNA测序允许与其他棒状杆菌物种进行准确区分。然而,这些方法在临床实验室中并不常用。基于联合实验室测试数据的多相分类方法至关重要。
{"title":"Corynebacterium durum and possibilities of its identification.","authors":"P Vítková, O Bechyňková, J Scharfen, V Buchta","doi":"10.61568/emi/11-6492/20250428/140417","DOIUrl":"10.61568/emi/11-6492/20250428/140417","url":null,"abstract":"<p><p>Corynebaterium (C.) durum is a part of the resident human oral microbiota. Its role in the aetiology of infectious diseases is ambiguous. With the increasing number of immunocompromised patients, it must be considered a potential opportunistic pathogen. It is isolated from the sputum, bronchoalveolar-lavage fluid, as well as blood, especially from immunocompromised patients with pneumonia. In that case, the critical steps involve a correct identification of Corynebacterium to the species level and right interpretation of the findings. The previously widely used commercial test for the identification of Corynebacteria (API Coryne, BioMerieux) is not suitable for all species, including C. durum, as its biotype number is not included in the database. But the obtained result can be compared with the available literature data. Chemotaxonomic and proteomic analysis (matrix-assisted laser desorption/ ionization - time of flight, MALDI-TOF MS) or 16S rRNA sequencing allow for accurate differentiation from the other Corynebacteria species. Nevertheless, these methods are not routinely used in clinical laboratories. A polyphasic approach to the taxonomy based on the data from combined laboratory tests is crucial.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 2","pages":"113-117"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144762339","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
COVID-19 in the practice of maternity hospitals of various degrees in the Czech Republic. 在捷克共和国不同程度的妇产医院开展COVID-19的实践。
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6445/20250128/139682
Hynek Heřman, A Tefr Faridová, K Trojanová, B Jalůvková, A Šinská, Radovan Pilka, O Šimetka, B Čečetková, J Janák, P Steyerová

Objective: Pregnancy is not considered a condition that increases the body's susceptibility to SARS-CoV-2 (severe-acute-respiratory-syndrome-related coronavirus-2) infection, but in the case of infection in pregnancy, there is an increased risk of a more severe course of COVID-19 (coronavirus disease-19). However, the course of infection in pregnancy is mild or asymptomatic in most cases. The main objective of the study in pregnant women with COVID-19 was to prove that the delivery method is not changed, and serious complications do not occur more frequently due to this disease.

Methods: In a retrospective, observational, multicentric study, the pregnant women positively tested to COVID-19 were admitted and subsequently gave birth in the period from 15 March 2020 to 15 March 2021. Data from the delivery departments of five centers in the Czech Republic during COVID-19 pandemic were analyzed in relation to the delivery method and time, COVID-19 symptoms and potential complications with respect to demographics and comorbidities of pregnant women. COVID-19 positivity was confirmed with PCR (polymerase-chain reaction). The Excel program was used during statistical analysis.

Results: During the observed study period, 236 pregnant women with COVID-19 were detected at study centers. Most of the patients were asymptomatic (59.7%). In symptomatic patients, most common symptoms were cough (52.6 %), cold (43.2%) and fever (37.9%), and COVID-19 pneumonia was diagnosed in 8 patients. The delivery was performed vaginally in 52.5% patients, the pregnancy was terminated by C-section (cesarean section) in 44.5%, per VEX (vacuum extractor) in 2.1% and per forcipem in 0.8% cases. The average week of pregnancy at the time of delivery was 38 (29-41) and preterm delivery was performed in 19.1% patients. The study results in pregnant women with COVID-19 demonstrated that the method of delivery was not changed and major delivery and neonatological complications did not develop in most cases. However, two presented serious courses of COVID-19 in pregnant women led to premature terminations of pregnancies. The only associated risk factor was the patient's obesity.

Conclusions: Although COVID-19 is a disease that is mostly asymptomatic in pregnant women or with only mild flu-like symptoms, it is associated with increased morbidity and mortality compared to pregnant women without COVID-19. The challenge for the future is the possibility of segregating patients into lowand high-risk groups based on proven risk factors, and consistent vaccination of pregnant women or women planning conception. In critical cases, the correct timing of premature termination of pregnancy and early indication of the beginning of fetal lung maturation is necessary.

目的:妊娠不被认为是增加机体对SARS-CoV-2(严重急性呼吸综合征相关冠状病毒-2)感染易感性的情况,但在妊娠感染的情况下,会增加发生更严重的COVID-19(冠状病毒病-19)病程的风险。然而,在大多数情况下,妊娠期感染的过程是轻微的或无症状的。对COVID-19孕妇进行研究的主要目的是证明分娩方式没有改变,严重并发症不会因该疾病而更频繁地发生。方法:在一项回顾性、观察性、多中心研究中,于2020年3月15日至2021年3月15日期间入院并随后分娩的COVID-19阳性孕妇。分析了捷克共和国五个中心的分娩部门在COVID-19大流行期间的分娩方式和时间、COVID-19症状和潜在并发症以及孕妇的人口统计学和合并症的数据。采用聚合酶链反应(PCR)检测COVID-19阳性。统计分析采用Excel程序。结果:在观察研究期间,在研究中心检测到236名感染COVID-19的孕妇。大多数患者无症状(59.7%)。在有症状的患者中,最常见的症状是咳嗽(52.6%)、感冒(43.2%)和发烧(37.9%),其中8例诊断为COVID-19肺炎。52.5%为顺产,44.5%为剖宫产,2.1%为真空抽吸器,0.8%为强行流产。分娩时平均妊娠周为38周(29-41周),早产率为19.1%。对COVID-19孕妇的研究结果表明,分娩方式没有改变,大多数病例没有发生重大分娩和新生儿并发症。然而,有两名孕妇出现严重的COVID-19病程,导致过早终止妊娠。唯一相关的危险因素是患者的肥胖。结论:尽管COVID-19是一种孕妇大多无症状或只有轻微流感样症状的疾病,但与未感染COVID-19的孕妇相比,其发病率和死亡率均有所增加。未来的挑战是根据已证实的危险因素将患者分为低风险组和高风险组的可能性,以及孕妇或计划怀孕的妇女持续接种疫苗的可能性。在危重病例中,正确的提前终止妊娠时机和胎儿肺成熟开始的早期指征是必要的。
{"title":"COVID-19 in the practice of maternity hospitals of various degrees in the Czech Republic.","authors":"Hynek Heřman, A Tefr Faridová, K Trojanová, B Jalůvková, A Šinská, Radovan Pilka, O Šimetka, B Čečetková, J Janák, P Steyerová","doi":"10.61568/emi/11-6445/20250128/139682","DOIUrl":"10.61568/emi/11-6445/20250128/139682","url":null,"abstract":"<p><strong>Objective: </strong>Pregnancy is not considered a condition that increases the body's susceptibility to SARS-CoV-2 (severe-acute-respiratory-syndrome-related coronavirus-2) infection, but in the case of infection in pregnancy, there is an increased risk of a more severe course of COVID-19 (coronavirus disease-19). However, the course of infection in pregnancy is mild or asymptomatic in most cases. The main objective of the study in pregnant women with COVID-19 was to prove that the delivery method is not changed, and serious complications do not occur more frequently due to this disease.</p><p><strong>Methods: </strong>In a retrospective, observational, multicentric study, the pregnant women positively tested to COVID-19 were admitted and subsequently gave birth in the period from 15 March 2020 to 15 March 2021. Data from the delivery departments of five centers in the Czech Republic during COVID-19 pandemic were analyzed in relation to the delivery method and time, COVID-19 symptoms and potential complications with respect to demographics and comorbidities of pregnant women. COVID-19 positivity was confirmed with PCR (polymerase-chain reaction). The Excel program was used during statistical analysis.</p><p><strong>Results: </strong>During the observed study period, 236 pregnant women with COVID-19 were detected at study centers. Most of the patients were asymptomatic (59.7%). In symptomatic patients, most common symptoms were cough (52.6 %), cold (43.2%) and fever (37.9%), and COVID-19 pneumonia was diagnosed in 8 patients. The delivery was performed vaginally in 52.5% patients, the pregnancy was terminated by C-section (cesarean section) in 44.5%, per VEX (vacuum extractor) in 2.1% and per forcipem in 0.8% cases. The average week of pregnancy at the time of delivery was 38 (29-41) and preterm delivery was performed in 19.1% patients. The study results in pregnant women with COVID-19 demonstrated that the method of delivery was not changed and major delivery and neonatological complications did not develop in most cases. However, two presented serious courses of COVID-19 in pregnant women led to premature terminations of pregnancies. The only associated risk factor was the patient's obesity.</p><p><strong>Conclusions: </strong>Although COVID-19 is a disease that is mostly asymptomatic in pregnant women or with only mild flu-like symptoms, it is associated with increased morbidity and mortality compared to pregnant women without COVID-19. The challenge for the future is the possibility of segregating patients into lowand high-risk groups based on proven risk factors, and consistent vaccination of pregnant women or women planning conception. In critical cases, the correct timing of premature termination of pregnancy and early indication of the beginning of fetal lung maturation is necessary.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 1","pages":"3-10"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144217586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Whole genome sequencing (WGS) characterisation of Neisseria meningitidis from invasive meningococcal disease in the Czech Republic in 2018-2024 - analysis of the impact of the COVID-19 pandemic. 2018-2024年捷克共和国侵袭性脑膜炎球菌病脑膜炎奈瑟菌的全基因组测序特征分析- COVID-19大流行的影响分析
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6445/20250128/139684
Z Okonji, M Honskus, M Musílek, P Křížová

Objective: To analyse the impact of the COVID-19 pandemic on the epidemiological situation of invasive meningococcal disease (IMD) and molecular characteristics of Neisseria meningitidis isolates causing IMD in the Czech Republic.

Material and methods: The study was based on IMD surveillance data for 2018-2024 (as of 27 May 2024), and all available N. meningitidis isolates from IMD of these years were subjected to whole genome sequencing (WGS). To analyse the impact of the COVID-19 pandemic, the study period was divided into three parts: the pre-COVID period (2018-2019), the COVID-19 pandemic period (2020-2022), and the post-COVID period (2023-2024).

Results: As a result of the implementation of the COVID-19 control measures, similar to other countries, there has been a decline in the incidence of air-borne infections including IMD in the Czech Republic. However, unlike many other countries, there has not been a resurgence of IMD in the Czech Republic following the release of these epidemiological measures. WGS characterisation of IMD isolates showed a gradual change in the population of meningococci causing IMD in the Czech Republic during the COVID-19 and post-COVID periods. For N. meningitidis isolates of serogroups C, W, and Y, a gradual and significant decline in overall heterogeneity can be observed - from ten different clonal complexes detected in the pre-COVID period to only three in the post-COVID years (cc11, cc23, and cc103). At the same time, a significant reduction was observed in N. meningitidis C isolates; cc11. In contrast, an increase in overall heterogeneity can be observed for N. meningitidis B isolates during the COVID-19 pandemic period, followed by its decline again to overall lowest values in the post-COVID period.

Conclusion: The fact that MenB vaccine and conjugate vaccine A, C, W, Y started to be covered by health insurance for young children (in May 2020) and adolescents (in January 2022) also appears to play a role in the persistent decline of IMD in the Czech Republic. In order to maintain the low incidence of IMD in the Czech Republic, it is desirable to continue vaccination with MenB vaccine and conjugated vaccine A, C, W, Y in accordance with the recommendations of the Czech Society of Vaccinology of the Czech Medical Association of Jan Evangelista Purkyně.

目的:分析2019冠状病毒病(COVID-19)大流行对捷克境内侵袭性脑膜炎球菌病(IMD)流行病学状况及引起IMD的脑膜炎奈瑟菌分离株分子特征的影响。材料和方法:该研究基于2018-2024年(截至2024年5月27日)的IMD监测数据,并对这些年来所有可获得的IMD脑膜炎奈索菌分离株进行了全基因组测序(WGS)。为了分析COVID-19大流行的影响,研究期分为三个部分:covid前期(2018-2019),covid大流行期(2020-2022)和covid后期(2023-2024)。结果:与其他国家一样,由于实施了COVID-19控制措施,捷克共和国包括IMD在内的空气传播感染的发病率有所下降。然而,与许多其他国家不同,在发布这些流行病学措施后,捷克共和国并没有再次出现疟疾。IMD分离株的WGS特征显示,在COVID-19和COVID-19后时期,捷克共和国引起IMD的脑膜炎球菌种群逐渐发生变化。对于C、W和Y血清群的脑膜炎梭菌分离株,可以观察到总体异质性逐渐显著下降——从covid前检测到的10种不同克隆复合物到covid后仅检测到3种(cc11、cc23和cc103)。同时,在C型脑膜炎奈瑟菌分离株中观察到显著减少;cc11。相反,在COVID-19大流行期间,可以观察到乙型脑膜炎奈瑟菌分离株的总体异质性增加,随后在COVID-19后时期再次下降至总体最低值。结论:MenB疫苗和A、C、W、Y结合疫苗开始被纳入幼儿(2020年5月)和青少年(2022年1月)的健康保险,这一事实似乎也在捷克共和国IMD持续下降中发挥了作用。为了保持捷克共和国的低发病率,按照捷克医学协会Jan Evangelista purkynyi的捷克疫苗学学会的建议,最好继续接种b型脑膜炎疫苗和A、C、W、Y结合疫苗。
{"title":"Whole genome sequencing (WGS) characterisation of Neisseria meningitidis from invasive meningococcal disease in the Czech Republic in 2018-2024 - analysis of the impact of the COVID-19 pandemic.","authors":"Z Okonji, M Honskus, M Musílek, P Křížová","doi":"10.61568/emi/11-6445/20250128/139684","DOIUrl":"https://doi.org/10.61568/emi/11-6445/20250128/139684","url":null,"abstract":"<p><strong>Objective: </strong>To analyse the impact of the COVID-19 pandemic on the epidemiological situation of invasive meningococcal disease (IMD) and molecular characteristics of Neisseria meningitidis isolates causing IMD in the Czech Republic.</p><p><strong>Material and methods: </strong>The study was based on IMD surveillance data for 2018-2024 (as of 27 May 2024), and all available N. meningitidis isolates from IMD of these years were subjected to whole genome sequencing (WGS). To analyse the impact of the COVID-19 pandemic, the study period was divided into three parts: the pre-COVID period (2018-2019), the COVID-19 pandemic period (2020-2022), and the post-COVID period (2023-2024).</p><p><strong>Results: </strong>As a result of the implementation of the COVID-19 control measures, similar to other countries, there has been a decline in the incidence of air-borne infections including IMD in the Czech Republic. However, unlike many other countries, there has not been a resurgence of IMD in the Czech Republic following the release of these epidemiological measures. WGS characterisation of IMD isolates showed a gradual change in the population of meningococci causing IMD in the Czech Republic during the COVID-19 and post-COVID periods. For N. meningitidis isolates of serogroups C, W, and Y, a gradual and significant decline in overall heterogeneity can be observed - from ten different clonal complexes detected in the pre-COVID period to only three in the post-COVID years (cc11, cc23, and cc103). At the same time, a significant reduction was observed in N. meningitidis C isolates; cc11. In contrast, an increase in overall heterogeneity can be observed for N. meningitidis B isolates during the COVID-19 pandemic period, followed by its decline again to overall lowest values in the post-COVID period.</p><p><strong>Conclusion: </strong>The fact that MenB vaccine and conjugate vaccine A, C, W, Y started to be covered by health insurance for young children (in May 2020) and adolescents (in January 2022) also appears to play a role in the persistent decline of IMD in the Czech Republic. In order to maintain the low incidence of IMD in the Czech Republic, it is desirable to continue vaccination with MenB vaccine and conjugated vaccine A, C, W, Y in accordance with the recommendations of the Czech Society of Vaccinology of the Czech Medical Association of Jan Evangelista Purkyně.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 1","pages":"20-30"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144217592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pertussis vaccination in pregnancy: a questionnaire survey of general practitioners in the South Moravian Region, 2024. 妊娠期百日咳疫苗接种:2024年南摩拉维亚地区全科医生问卷调查
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6568/20250808/141318
V Šponiar Ovesná, R Ciupek, R Boháčová, L Matulová

The aim was to compare the general practitioners' attitudes towards pertussis vaccination in pregnancy in the South Moravian Region in 2019 and 2024. Using a questionnaire survey, a significant increase was found in active recommendation of vaccination, in the interest from pregnant women and in vaccinations completed in general practitioners' offices. The main factors behind this shift were increased media coverage of pertussis and growing awareness of the importance of vaccination for the protection of young children. The results point to the need to promote interdisciplinary collaboration between GPs and gynaecologists and to consider the possibility to cover vaccination by health insurance.

目的是比较2019年和2024年南摩拉维亚地区全科医生对妊娠期百日咳疫苗接种的态度。通过问卷调查,发现积极推荐接种疫苗、孕妇感兴趣以及在全科医生办公室完成接种疫苗的人数显著增加。这一转变背后的主要因素是媒体对百日咳的报道增加,以及人们日益认识到接种疫苗对保护幼儿的重要性。结果表明,有必要促进全科医生和妇科医生之间的跨学科合作,并考虑将疫苗接种纳入健康保险的可能性。
{"title":"Pertussis vaccination in pregnancy: a questionnaire survey of general practitioners in the South Moravian Region, 2024.","authors":"V Šponiar Ovesná, R Ciupek, R Boháčová, L Matulová","doi":"10.61568/emi/11-6568/20250808/141318","DOIUrl":"https://doi.org/10.61568/emi/11-6568/20250808/141318","url":null,"abstract":"<p><p>The aim was to compare the general practitioners' attitudes towards pertussis vaccination in pregnancy in the South Moravian Region in 2019 and 2024. Using a questionnaire survey, a significant increase was found in active recommendation of vaccination, in the interest from pregnant women and in vaccinations completed in general practitioners' offices. The main factors behind this shift were increased media coverage of pertussis and growing awareness of the importance of vaccination for the protection of young children. The results point to the need to promote interdisciplinary collaboration between GPs and gynaecologists and to consider the possibility to cover vaccination by health insurance.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 3","pages":"180-183"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145240521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Still a neglected tropical disease. Epidemiological analysis of leishmaniasis in the Czech Republic in 1997-2024. 仍然是一种被忽视的热带疾病。捷克共和国1997-2024年利什曼病流行病学分析
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2025-01-01 DOI: 10.61568/emi/11-6600/20251001/141814
J Velechovská, K Fabiánová

Aim: More than one million people are estimated to be infected by Leishmania annually worldwide. Due to the high movement of people and animals in today's globalized world as a result of tourism, migration, war conflicts, and/or climate change, the spread of leishmaniasis to new areas previously regarded as non-endemic has recently been reported. The emergence of phlebotomine sandflies, vectors of Leishmania, in neighbouring countries triggered our interest in leishmaniasis cases reported to the EPIDAT and ISIN databases in the Czech Republic between 1997 and 2024.

Materials and methods: Summary data on the cases reported to the EPIDAT and ISIN databases under the ICD-10 code B55 Leishmaniasis in 1997-2024 were analysed by country of import, travel purpose, nationality, age, sex, reporting date, disease form, agent of infection, and case fatality.

Results: Between 1997 and 2024, a total of 45 cases of leishmaniasis were reported, 40 of which in Czech citizens. Most cases were imported from the European Union (16) and Latin America (13) countries. Men were 3.5 times more often affected than women (ratio 7:2). The patients were mainly Czech citizens returning from travel abroad (24 men, seven women). The most common form of the disease, if indicated, was cutaneous leishmaniasis (17 cases). None of the cases was reported in the age groups under 1 year and 70 years and older. The causative Leishmania species was only indicated in four cases. One death associated with leishmaniasis was reported (case fatality rate 2.2 %).

Conclusions: The number of cases reported annually remained more or less constant between 1997 and 2024. However, more cases might emerge in the future due to increased movement of people and animals and/or climate change. Therefore, it is important to promote the One Health approach and consider the introduction of leishmaniasis surveillance in the Czech Republic.

目的:据估计,全世界每年有一百多万人感染利什曼原虫。在当今全球化的世界中,由于旅游、移民、战争冲突和/或气候变化导致人员和动物的大量流动,最近有报告称,利什曼病向以前被视为非流行地区的新地区蔓延。利什曼病媒介白蛉在邻国的出现引发了我们对1997年至2024年期间捷克共和国向EPIDAT和ISIN数据库报告的利什曼病病例的兴趣。材料和方法:对1997-2024年根据ICD-10代码B55向EPIDAT和ISIN数据库报告的利什曼病病例的摘要数据进行了按进口国家、旅行目的、国籍、年龄、性别、报告日期、疾病形式、感染源和病死率进行分析。结果:1997年至2024年,共报告了45例利什曼病,其中40例为捷克公民。大多数病例来自欧盟(16例)和拉丁美洲(13例)国家。男性受影响的频率是女性的3.5倍(比例为7:2)。患者主要为从国外旅游归来的捷克公民(男性24人,女性7人)。最常见的疾病形式是皮肤利什曼病(17例)。1岁以下和70岁及以上年龄组无病例报告。仅在4例病例中发现致病性利什曼原虫。报告了一例与利什曼病有关的死亡(病死率2.2%)。结论:1997年至2024年间,每年报告的病例数基本保持不变。然而,由于人和动物流动增加和/或气候变化,未来可能出现更多病例。因此,重要的是促进“同一个健康”方针,并考虑在捷克共和国开展利什曼病监测。
{"title":"Still a neglected tropical disease. Epidemiological analysis of leishmaniasis in the Czech Republic in 1997-2024.","authors":"J Velechovská, K Fabiánová","doi":"10.61568/emi/11-6600/20251001/141814","DOIUrl":"https://doi.org/10.61568/emi/11-6600/20251001/141814","url":null,"abstract":"<p><strong>Aim: </strong>More than one million people are estimated to be infected by Leishmania annually worldwide. Due to the high movement of people and animals in today's globalized world as a result of tourism, migration, war conflicts, and/or climate change, the spread of leishmaniasis to new areas previously regarded as non-endemic has recently been reported. The emergence of phlebotomine sandflies, vectors of Leishmania, in neighbouring countries triggered our interest in leishmaniasis cases reported to the EPIDAT and ISIN databases in the Czech Republic between 1997 and 2024.</p><p><strong>Materials and methods: </strong>Summary data on the cases reported to the EPIDAT and ISIN databases under the ICD-10 code B55 Leishmaniasis in 1997-2024 were analysed by country of import, travel purpose, nationality, age, sex, reporting date, disease form, agent of infection, and case fatality.</p><p><strong>Results: </strong>Between 1997 and 2024, a total of 45 cases of leishmaniasis were reported, 40 of which in Czech citizens. Most cases were imported from the European Union (16) and Latin America (13) countries. Men were 3.5 times more often affected than women (ratio 7:2). The patients were mainly Czech citizens returning from travel abroad (24 men, seven women). The most common form of the disease, if indicated, was cutaneous leishmaniasis (17 cases). None of the cases was reported in the age groups under 1 year and 70 years and older. The causative Leishmania species was only indicated in four cases. One death associated with leishmaniasis was reported (case fatality rate 2.2 %).</p><p><strong>Conclusions: </strong>The number of cases reported annually remained more or less constant between 1997 and 2024. However, more cases might emerge in the future due to increased movement of people and animals and/or climate change. Therefore, it is important to promote the One Health approach and consider the introduction of leishmaniasis surveillance in the Czech Republic.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"74 4","pages":"216-223"},"PeriodicalIF":0.5,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145985925","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Asymptomatic SARS-CoV-2 infection in recipients of hematopoietic stem cells in the Omicron period. 造血干细胞接受者在 Omicron 期间无症状 SARS-CoV-2 感染。
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-01-01 DOI: 10.61568/emi/11-6352/20240726/138065
M Šťastná-Marková, K Roubalová, P Hainz, J Kryštofová, K Labská, T Vosáhlová, Š Němečková

Aim: We aimed to determine the prevalence of SARS-CoV-2 infection, including both symptomatic and asymptomatic courses, and to identify predictors of asymptomatic or symptomatic SARS-CoV-2 infection in patients within seven months after allo-HSCT (allogenic hematopoietic stem cell transplantation) in the Omicron period.

Methods: Prevalence of the past SARS-CoV-2 infection was determined in patients within seven months after allo-HSCT in the Omicron period using the cellular and humoral immune response against the SARS-CoV-2 nucleoprotein (NCP).

Results: Positive markers of past infection were identified in 45.2% of patients (n = 42). The infection was asymptomatic in 68.4% of anti-NCP positive patients. The search for risk factors for symptomatic SARS-CoV-2 infection in allo-HSCT recipients revealed that a low level of B cell reconstitution was the only significantly associated risk factor.

Conclusion: A high proportion of allo-HSCT recipients who were asymptomatically infected within up to seven months after transplantation from 2022 to 2023 despite being immunosuppressed and unvaccinated indicates an attenuation of the circulating virus and may signal less risk for transplanted patients from SARS-CoV-2 infection in the Omicron period. Vaccination of these patients against SARS-CoV-2 was shown to be associated with a low but significant risk of exacerbation of cured chronic GVHD (graft versus host disease) and the risk of de novo GVHD. The low level of B-cell reconstitution was the only significant risk factor for symptomatic SARS-CoV-2 infection in HSCT recipients.

目的:我们旨在确定奥米克龙时期异基因造血干细胞移植(allo-HSCT)后七个月内的患者感染SARS-CoV-2(包括无症状和无症状病程)的流行率,并确定无症状或有症状的SARS-CoV-2感染的预测因素:方法:利用针对 SARS-CoV-2 核蛋白(NCP)的细胞和体液免疫反应,测定 Omicron 时期异基因造血干细胞移植后 7 个月内患者既往感染 SARS-CoV-2 的流行率:结果:45.2%的患者(42 人)发现了既往感染的阳性标记物。68.4%的抗 NCP 阳性患者无症状。在寻找异体 HSCT 受者感染无症状 SARS-CoV-2 的风险因素时发现,B 细胞重建水平低是唯一显著相关的风险因素:尽管免疫抑制且未接种疫苗,但在 2022 年至 2023 年期间,有很高比例的异体 HSCT 受者在移植后最多 7 个月内无症状感染,这表明循环病毒在衰减,可能预示着移植患者在 Omicron 期间感染 SARS-CoV-2 的风险较低。研究表明,为这些患者接种 SARS-CoV-2 疫苗与已治愈的慢性 GVHD(移植物抗宿主疾病)恶化的风险和新发 GVHD 的风险相关,但风险较低。B 细胞重建水平低是造血干细胞移植受者感染 SARS-CoV-2 症状的唯一重要风险因素。
{"title":"Asymptomatic SARS-CoV-2 infection in recipients of hematopoietic stem cells in the Omicron period.","authors":"M Šťastná-Marková, K Roubalová, P Hainz, J Kryštofová, K Labská, T Vosáhlová, Š Němečková","doi":"10.61568/emi/11-6352/20240726/138065","DOIUrl":"https://doi.org/10.61568/emi/11-6352/20240726/138065","url":null,"abstract":"<p><strong>Aim: </strong>We aimed to determine the prevalence of SARS-CoV-2 infection, including both symptomatic and asymptomatic courses, and to identify predictors of asymptomatic or symptomatic SARS-CoV-2 infection in patients within seven months after allo-HSCT (allogenic hematopoietic stem cell transplantation) in the Omicron period.</p><p><strong>Methods: </strong>Prevalence of the past SARS-CoV-2 infection was determined in patients within seven months after allo-HSCT in the Omicron period using the cellular and humoral immune response against the SARS-CoV-2 nucleoprotein (NCP).</p><p><strong>Results: </strong>Positive markers of past infection were identified in 45.2% of patients (n = 42). The infection was asymptomatic in 68.4% of anti-NCP positive patients. The search for risk factors for symptomatic SARS-CoV-2 infection in allo-HSCT recipients revealed that a low level of B cell reconstitution was the only significantly associated risk factor.</p><p><strong>Conclusion: </strong>A high proportion of allo-HSCT recipients who were asymptomatically infected within up to seven months after transplantation from 2022 to 2023 despite being immunosuppressed and unvaccinated indicates an attenuation of the circulating virus and may signal less risk for transplanted patients from SARS-CoV-2 infection in the Omicron period. Vaccination of these patients against SARS-CoV-2 was shown to be associated with a low but significant risk of exacerbation of cured chronic GVHD (graft versus host disease) and the risk of de novo GVHD. The low level of B-cell reconstitution was the only significant risk factor for symptomatic SARS-CoV-2 infection in HSCT recipients.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"73 3","pages":"140-146"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142693984","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Th17 lymphocytes and Interleukin-17A during the course of severe community acquired pneumonia, comparison with etiology and outcome. 重症社区获得性肺炎病程中的 Th17 淋巴细胞和白细胞介素-17A,与病因和预后的比较。
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-01-01 DOI: 10.61568/emi/11-6352/20240726/138064
M Moravec, T Nejtek, M Ibrahimová, R Zazula, M Müller

Objective: Observational study of patients diagnosed with severe community acquired pneumonia (sCAP) carried out to evaluate levels of interleukin 17A (IL-17A) and T helper 17 (Th17) lymphocyte count in peripheral circulation and bronchoalveolar lavage fluid (BALF) in the early course of sCAP of different etiology and to compare them with patient's characteristics and outcome.

Material and methods: Cohort of 74 patients with sCAP was analyzed and respective microbial etiology established. According to pathogens, 3 subgroups of patients were created: bacterial, viral and mixed etiology. Th17 count and IL-17A levels were measured using flow cytometry and ELISA in peripheral blood and BALF. Data were compared with respect to etiology and their correlation with 30and 90-day mortality was statistically analyzed.

Results: There was no statistically significant correlation in Th17 count and IL-17A levels in blood and BALF between etiological subgroups of CAP and no correlation was found with respect to measured parameters and 30and 90-day mortality. Nevertheless, increased Th17 cell count and IL-17A levels in peripheral blood, but not in BALF, in the early course of sCAP are correlated with increased relative risk of death from sCAP. Other factors increasing relative risk of death in patients with sCAP found in our cohort were male sex and advanced age.

Conclusions: Systemic Th17 count and IL-17A levels in the early course (up to 7 days from admission) of sCAP may be correlated with severity and outcome of sCAP.

研究目的对确诊为社区获得性重症肺炎(sCAP)的患者进行观察性研究,以评估不同病因的社区获得性重症肺炎早期外周循环和支气管肺泡灌洗液(BALF)中白细胞介素17A(IL-17A)和T辅助17(Th17)淋巴细胞计数的水平,并将其与患者的特征和预后进行比较:对 74 例 sCAP 患者进行了分析,并确定了各自的微生物病因。根据病原体将患者分为三个亚组:细菌、病毒和混合病因。使用流式细胞术和酶联免疫吸附法测定了外周血和肺泡液中的 Th17 数量和 IL-17A 水平。比较了病因数据,并对其与 30 天和 90 天死亡率的相关性进行了统计分析:结果:CAP不同病因亚组之间血液和BALF中的Th17细胞计数和IL-17A水平没有统计学意义上的相关性,测量参数与30天和90天死亡率也没有相关性。尽管如此,在 sCAP 早期,外周血中 Th17 细胞数量和 IL-17A 水平的增加与 sCAP 死亡相对风险的增加相关,而在 BALF 中则不相关。在我们的队列中发现,增加sCAP患者相对死亡风险的其他因素是男性和高龄:结论:sCAP 早期(入院后 7 天内)的全身 Th17 细胞计数和 IL-17A 水平可能与 sCAP 的严重程度和预后相关。
{"title":"Th17 lymphocytes and Interleukin-17A during the course of severe community acquired pneumonia, comparison with etiology and outcome.","authors":"M Moravec, T Nejtek, M Ibrahimová, R Zazula, M Müller","doi":"10.61568/emi/11-6352/20240726/138064","DOIUrl":"10.61568/emi/11-6352/20240726/138064","url":null,"abstract":"<p><strong>Objective: </strong>Observational study of patients diagnosed with severe community acquired pneumonia (sCAP) carried out to evaluate levels of interleukin 17A (IL-17A) and T helper 17 (Th17) lymphocyte count in peripheral circulation and bronchoalveolar lavage fluid (BALF) in the early course of sCAP of different etiology and to compare them with patient's characteristics and outcome.</p><p><strong>Material and methods: </strong>Cohort of 74 patients with sCAP was analyzed and respective microbial etiology established. According to pathogens, 3 subgroups of patients were created: bacterial, viral and mixed etiology. Th17 count and IL-17A levels were measured using flow cytometry and ELISA in peripheral blood and BALF. Data were compared with respect to etiology and their correlation with 30and 90-day mortality was statistically analyzed.</p><p><strong>Results: </strong>There was no statistically significant correlation in Th17 count and IL-17A levels in blood and BALF between etiological subgroups of CAP and no correlation was found with respect to measured parameters and 30and 90-day mortality. Nevertheless, increased Th17 cell count and IL-17A levels in peripheral blood, but not in BALF, in the early course of sCAP are correlated with increased relative risk of death from sCAP. Other factors increasing relative risk of death in patients with sCAP found in our cohort were male sex and advanced age.</p><p><strong>Conclusions: </strong>Systemic Th17 count and IL-17A levels in the early course (up to 7 days from admission) of sCAP may be correlated with severity and outcome of sCAP.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"73 3","pages":"131-139"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142694011","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Active surveillance of hospital-acquired infections in Pediatric Intensive Care Unit: a single center study. 儿科重症监护病房医院获得性感染的主动监测:一项单中心研究
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-01-01 DOI: 10.61568/emi/11-6390/20241024/138874
M Fulová, M Kotrbancová, J Perželová, A Bražinová

Objective: The aim of our study was to describe and analyze HAI incidence, etiology and risk factors in pediatric intensive care unit (ICU).

Background: Intensive care patients are at high risk of hospital-acquired infections (HAI) due to their underlying diseases and exposure to invasive devices.

Methods: The study group consisted of patients admitted to children's hospital ICU for more than 2 days during a six-month period (267 patients, 1570 patient-days). We used the European Centre for Disease Prevention and Control standard protocol HAI-Net ICU v2.2 for data collection.

Results: HAI occurred in 17 (6.4%) included patients (10.8 infections per 1000 patient-days). The most frequent were catheter-related bloodstream infections (33%, 7.6 per 1000 catheter-days) and intubation-associated pneumonia (25%, 10.9 per 1000 intubation-days). Gram-negative bacteria (Pseudomonas aeruginosa, Klebsiella spp.) were identified as the most common etiological agents. Significantly higher risk of HAI had patients with central venous catheter (OR: 14.5, 95% CI 3.2-65.1), intubated (OR: 14.4, 95% CI 4.4-46.2), with Pediatric Index of Mortality score higher than 10 (OR: 17, 95% CI 2.7-111.5) and with previous bacterial or/ and fungal colonization (OR: 30.6, 95% CI 9.2-101.3).

Conclusions: Active surveillance identified unreported HAI cases and proved to be an effective tool of infection control.

目的:本研究的目的是描述和分析儿科重症监护病房(ICU) HAI的发病率、病因和危险因素。背景:重症监护患者由于其潜在疾病和暴露于侵入性器械,是医院获得性感染(HAI)的高危人群。方法:研究组为6个月期间在儿童医院ICU住院2天以上的患者(267例,1570患者日)。我们使用欧洲疾病预防和控制中心标准协议HAI-Net ICU v2.2进行数据收集。结果:17例(6.4%)患者发生HAI(10.8例/ 1000患者日)。最常见的是导管相关血流感染(33%,每1000导管日7.6例)和插管相关肺炎(25%,每1000插管日10.9例)。革兰氏阴性菌(铜绿假单胞菌、克雷伯氏菌)是最常见的病原。中心静脉置管(OR: 14.5, 95% CI 3.2-65.1)、插管(OR: 14.4, 95% CI 4.4-46.2)、儿科死亡率指数评分高于10 (OR: 17, 95% CI 2.7-111.5)、既往有细菌或/和真菌定植(OR: 30.6, 95% CI 9.2-101.3)的患者发生HAI的风险明显较高。结论:主动监测发现了未报告的HAI病例,并被证明是感染控制的有效工具。
{"title":"Active surveillance of hospital-acquired infections in Pediatric Intensive Care Unit: a single center study.","authors":"M Fulová, M Kotrbancová, J Perželová, A Bražinová","doi":"10.61568/emi/11-6390/20241024/138874","DOIUrl":"https://doi.org/10.61568/emi/11-6390/20241024/138874","url":null,"abstract":"<p><strong>Objective: </strong>The aim of our study was to describe and analyze HAI incidence, etiology and risk factors in pediatric intensive care unit (ICU).</p><p><strong>Background: </strong>Intensive care patients are at high risk of hospital-acquired infections (HAI) due to their underlying diseases and exposure to invasive devices.</p><p><strong>Methods: </strong>The study group consisted of patients admitted to children's hospital ICU for more than 2 days during a six-month period (267 patients, 1570 patient-days). We used the European Centre for Disease Prevention and Control standard protocol HAI-Net ICU v2.2 for data collection.</p><p><strong>Results: </strong>HAI occurred in 17 (6.4%) included patients (10.8 infections per 1000 patient-days). The most frequent were catheter-related bloodstream infections (33%, 7.6 per 1000 catheter-days) and intubation-associated pneumonia (25%, 10.9 per 1000 intubation-days). Gram-negative bacteria (Pseudomonas aeruginosa, Klebsiella spp.) were identified as the most common etiological agents. Significantly higher risk of HAI had patients with central venous catheter (OR: 14.5, 95% CI 3.2-65.1), intubated (OR: 14.4, 95% CI 4.4-46.2), with Pediatric Index of Mortality score higher than 10 (OR: 17, 95% CI 2.7-111.5) and with previous bacterial or/ and fungal colonization (OR: 30.6, 95% CI 9.2-101.3).</p><p><strong>Conclusions: </strong>Active surveillance identified unreported HAI cases and proved to be an effective tool of infection control.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"73 4","pages":"192-197"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142900383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of Babesia spp. in ticks and in blood of dogs and red deer in the Czech Republic. 在捷克共和国的蜱虫以及狗和鹿血液中检测到巴贝西亚原虫。
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-01-01 DOI: 10.61568/emi/11-6352/20240726/138063
A Lukavská, K Kybicová, P Míchalová, J Navrátil, J Lamka, P Schánilec

Aim: To determine the occurrence of species of Babesia potentially pathogenic for humans in ticks and in the blood of dogs and deer in selected regions of the Czech Republic. To compare the prevalence of Babesia spp. in ticks with that of other tick-borne pathogens, such as Borrelia spp., Anaplasma spp., and Rickettsia spp.

Material and methods: Tick samples were individually homogenized. DNA was isolated from tick samples and animal blood. The detection of Babesia spp. was based on PCR of the 18S rRNA gene, and the identification to the species level was done by sequencing analysis of the PCR products.

Results: In 2014-2016, ticks and blood of dogs and deer collected in various areas of the Czech Republic were analyzed. In a set of 675 Ixodes ricinus ticks, the positivity rate for Babesia spp. varied from 0.0 to 3.3 %. The species Babesia venatorum, Babesia microti (both pathogenic for humans), and Babesia capreoli were identified in ticks by sequencing analysis. The prevalence of Babesia spp. in ticks compared to that of other pathogens such as Borrelia burgdorferi s. l. (29.3 %) or Anaplasma phagocytophilum (4.9 %) was lower and comparable to that of Rickettsia spp. (1.6 %). Co-infection with Borrelia burgdorferi s.l (B. venatorum - Borrelia garinii, Borrelia afzelii, and B. microti - B. afzelii) was found in a third of Babesia spp. positive ticks. Out of 109 dog blood samples, 3.7 % were positive for Babesia spp., specifically Babesia gibsoni and Babesia vulpes. Of 50 blood samples of wild deer from the natural ecosystem, the positivity rate reached 4.0 %. The species Babesia divergens, a major human pathogen, was identified. Out of 80 blood samples from farmed deer, 5.0 % were positive for the species Babesia odocoilei. Nucleotide sequences of the agents causing human babesiosis were deposited in the gene bank under accession numbers ON892053 (B. venatorum), ON892061 (B. microti), and ON892067 (B. divergens).

Conclusions: Using PCR of the 18S rRNA gene and amplicon sequencing, three species of Babesia causing human babesiosis were detected in the Czech Republic: B. divergens, B. venatorum, and B. microti. Babesia spp. pathogenic for humans pose a potential risk especially in asplenic and immunocompromised patients. The detected co-infections with Borrelia spp. can be the cause of a complicated course of the disease.

目的:确定捷克共和国部分地区蜱虫以及狗和鹿血液中可能对人类致病的巴贝西亚原虫的种类。比较蜱虫中巴贝斯菌属与其他蜱传病原体(如鲍氏菌属、阿那普拉斯菌属和立克次体属)的流行情况:蜱虫样本单独均质。从蜱虫样本和动物血液中分离 DNA。巴贝西亚原虫的检测基于 18S rRNA 基因的聚合酶链式反应(PCR),并通过对 PCR 产物的测序分析进行物种鉴定:结果:分析了 2014-2016 年在捷克共和国不同地区采集的蜱虫以及狗和鹿的血液。在一组 675 只蓖麻蜱中,巴贝西亚原虫的阳性率从 0.0% 到 3.3% 不等。通过测序分析,确定了蜱中的巴贝西亚原虫(Babesia venatorum)、微小巴贝西亚原虫(Babesia microti,两者均对人类致病)和卡普里奥利巴贝西亚原虫(Babesia capreoli)。与其他病原体如布氏杆菌(29.3%)或噬细胞嗜血杆菌(4.9%)相比,蜱虫中巴贝斯菌的流行率较低,与立克次体(1.6%)的流行率相当。在三分之一的巴贝西亚原虫阳性蜱虫中,发现了与布氏杆菌(B. venatorum - Borrelia garinii、Borrelia afzelii 和 B. microti - B. afzelii)同时感染的情况。在 109 份狗的血液样本中,3.7% 对巴贝西亚原虫属呈阳性,特别是吉布森巴贝西亚原虫和秃鹫巴贝西亚原虫。在自然生态系统中采集的 50 份野鹿血液样本中,阳性率达到 4.0%。鉴定出的巴贝西亚原虫是一种主要的人类病原体。在 80 份养殖鹿的血液样本中,5.0% 的样本对奥多科莱巴贝西亚原虫呈阳性反应。导致人类巴贝西亚原虫病的病原体核苷酸序列已存入基因库,登录号分别为 ON892053(B. venatorum)、ON892061(B. microti)和 ON892067(B. divergens):结论:通过 18S rRNA 基因的 PCR 和扩增子测序,在捷克共和国检测到了引起人类巴贝西亚原虫病的三种巴贝西亚原虫:B.divergens、B.venatorum 和 B.microti。对人类具有致病性的巴贝西亚原虫对脾功能不全和免疫力低下的患者构成潜在风险。已发现的包柔氏菌属合并感染可能会导致病程复杂。
{"title":"Detection of Babesia spp. in ticks and in blood of dogs and red deer in the Czech Republic.","authors":"A Lukavská, K Kybicová, P Míchalová, J Navrátil, J Lamka, P Schánilec","doi":"10.61568/emi/11-6352/20240726/138063","DOIUrl":"10.61568/emi/11-6352/20240726/138063","url":null,"abstract":"<p><strong>Aim: </strong>To determine the occurrence of species of Babesia potentially pathogenic for humans in ticks and in the blood of dogs and deer in selected regions of the Czech Republic. To compare the prevalence of Babesia spp. in ticks with that of other tick-borne pathogens, such as Borrelia spp., Anaplasma spp., and Rickettsia spp.</p><p><strong>Material and methods: </strong>Tick samples were individually homogenized. DNA was isolated from tick samples and animal blood. The detection of Babesia spp. was based on PCR of the 18S rRNA gene, and the identification to the species level was done by sequencing analysis of the PCR products.</p><p><strong>Results: </strong>In 2014-2016, ticks and blood of dogs and deer collected in various areas of the Czech Republic were analyzed. In a set of 675 Ixodes ricinus ticks, the positivity rate for Babesia spp. varied from 0.0 to 3.3 %. The species Babesia venatorum, Babesia microti (both pathogenic for humans), and Babesia capreoli were identified in ticks by sequencing analysis. The prevalence of Babesia spp. in ticks compared to that of other pathogens such as Borrelia burgdorferi s. l. (29.3 %) or Anaplasma phagocytophilum (4.9 %) was lower and comparable to that of Rickettsia spp. (1.6 %). Co-infection with Borrelia burgdorferi s.l (B. venatorum - Borrelia garinii, Borrelia afzelii, and B. microti - B. afzelii) was found in a third of Babesia spp. positive ticks. Out of 109 dog blood samples, 3.7 % were positive for Babesia spp., specifically Babesia gibsoni and Babesia vulpes. Of 50 blood samples of wild deer from the natural ecosystem, the positivity rate reached 4.0 %. The species Babesia divergens, a major human pathogen, was identified. Out of 80 blood samples from farmed deer, 5.0 % were positive for the species Babesia odocoilei. Nucleotide sequences of the agents causing human babesiosis were deposited in the gene bank under accession numbers ON892053 (B. venatorum), ON892061 (B. microti), and ON892067 (B. divergens).</p><p><strong>Conclusions: </strong>Using PCR of the 18S rRNA gene and amplicon sequencing, three species of Babesia causing human babesiosis were detected in the Czech Republic: B. divergens, B. venatorum, and B. microti. Babesia spp. pathogenic for humans pose a potential risk especially in asplenic and immunocompromised patients. The detected co-infections with Borrelia spp. can be the cause of a complicated course of the disease.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"73 3","pages":"124-130"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142694008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Occurrence of Francicella tularensis subsp. holarctica in haematophagous arthropods in the Breclav district in 2022. 2022 年布雷克拉夫地区食血节肢动物中的 Francicella tularensis subsp.
IF 0.5 4区 医学 Q4 MICROBIOLOGY Pub Date : 2024-01-01 DOI: 10.61568/emi/11-6352/20240726/138066
K Mravcová, S Zadražilová, I Vlčková, H Orlíková, M Malý, J Kynčl, J Mendel, Z Hubálek, S Šikutová, I Rudolf

Tularemia is a zoonosis caused by Francisella tularensis, a gram-negative aerobic bacterium belonging to the class of Gammaproteobacteria and the family Francisellaceae. Despite its undeniable importance for human health, there is little data on the current distribution of F. tularensis in various hematophagous arthropods. The aim of this study was to perform a mass molecular screening of different possible hematophagous vectors: ticks (4348 ticks of the species Ixodes ricinus, Dermacentor reticulatus, and Haemaphysalis concinna), mosquitoes (4100 specimens of Aedes vexans), and blackflies (6900 specimens of the Simulium spp.) for the presence of F. tularensis in the Břeclav district in 2022. Only two specimens were positive for the specific DNA of Francisella tularensis subsp. holarctica. Both samples originated from D. reticulatus, one collected from infested roe deer and the other included in a pooled sample (n = 10). Both positive samples were sequenced, and the presence of F. tularensis subsp. holarctica was confirmed. In addition, the absence of F. tularensis in mosquitoes and black flies was documented.

土拉菌病是一种由土拉弗朗西斯菌引起的人畜共患疾病,土拉弗朗西斯菌是一种革兰氏阴性需氧细菌,属于伽马蛋白杆菌属和弗朗西斯菌科。尽管土拉弗氏菌对人类健康的重要性毋庸置疑,但目前有关其在各种食血节肢动物中分布的数据却很少。本研究的目的是对 2022 年布热克拉夫地区可能的噬血媒介:蜱(4348 只,分别为 Ixodes ricinus、Dermacentor reticulatus 和 Haemaphysalis concinna)、蚊子(4100 只伊蚊标本)和黑蝇(6900 只蚋标本)进行大规模分子筛查,以确定是否存在土拉雷氏菌。只有两个标本的土拉弗氏菌亚种的特异性 DNA 呈阳性。两份样本均来自网纹鹿,一份采集自受侵染的狍子,另一份包含在一份集合样本(n = 10)中。对这两个阳性样本都进行了测序,证实了 F. tularensis subsp.此外,还发现蚊子和黑蝇中没有 F. tularensis。
{"title":"Occurrence of Francicella tularensis subsp. holarctica in haematophagous arthropods in the Breclav district in 2022.","authors":"K Mravcová, S Zadražilová, I Vlčková, H Orlíková, M Malý, J Kynčl, J Mendel, Z Hubálek, S Šikutová, I Rudolf","doi":"10.61568/emi/11-6352/20240726/138066","DOIUrl":"10.61568/emi/11-6352/20240726/138066","url":null,"abstract":"<p><p>Tularemia is a zoonosis caused by Francisella tularensis, a gram-negative aerobic bacterium belonging to the class of Gammaproteobacteria and the family Francisellaceae. Despite its undeniable importance for human health, there is little data on the current distribution of F. tularensis in various hematophagous arthropods. The aim of this study was to perform a mass molecular screening of different possible hematophagous vectors: ticks (4348 ticks of the species Ixodes ricinus, Dermacentor reticulatus, and Haemaphysalis concinna), mosquitoes (4100 specimens of Aedes vexans), and blackflies (6900 specimens of the Simulium spp.) for the presence of F. tularensis in the Břeclav district in 2022. Only two specimens were positive for the specific DNA of Francisella tularensis subsp. holarctica. Both samples originated from D. reticulatus, one collected from infested roe deer and the other included in a pooled sample (n = 10). Both positive samples were sequenced, and the presence of F. tularensis subsp. holarctica was confirmed. In addition, the absence of F. tularensis in mosquitoes and black flies was documented.</p>","PeriodicalId":54374,"journal":{"name":"Epidemiologie Mikrobiologie Imunologie","volume":"73 3","pages":"147-152"},"PeriodicalIF":0.5,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142694009","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Epidemiologie Mikrobiologie Imunologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1